Overview

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
To compare the rate and extent of absorption of doxycycline tablet (Par) versus doxycycline capsule (Monodox)(Oclassen).
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Anapharm
Treatments:
Doxycycline